16+
Major trials tracked
Targeted & bispecific oncology · Live ClinicalTrials.gov data
Teclistamab (Tecvayli) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 teclistamab trials on ClinicalTrials.gov by enrolment, 9 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2027. Refreshed daily — add up to four competitors to compare pipelines side by side.
10
Phase 3 trials
9
Actively recruiting
Dec 2027
Next phase 3 primary completion
9,546
Participants across trials
Janssen Research & Development, LLC
Lead sponsor by trial count
teclistamab (16)16 active2021–2038
teclistamab
'21
'23
'25
'27
'29
'31
'33
'35
'37
teclistamab
MajesTEC-3P3
MajesTEC-4P3
MajesTEC-7P3
HD10/DSMMXXP2
MajesTEC-9P3
MASTER-2P2
MonumenTAL-6P3
IFm2022-01P2
MMRC Horizon One: RRMM (MMRC-099)P2
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple MyelomaP3
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.P2
TRIlogy-4P3
TRIlogy-5P3
iFITP3
AugMMentP3
BLOOD-doseP4
Upcoming readouts
14 ahead · teclistamab
Select a trial to load its full ClinicalTrials.gov record.
Key teclistamab trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07474961 | BLOOD-dose — BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. | Phase 4 | Not yet recruiting | Dec 2036 |
| NCT06208150 | MonumenTAL-6 — A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, a… | Phase 3 | Recruiting | Apr 2026 |
| NCT07138209 | A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd… | Phase 3 | Recruiting | Dec 2027 |
| NCT05243797 | MajesTEC-4 — Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone … | Phase 3 | Recruiting | Apr 2028 |
| NCT07258511 | TRIlogy-4 — A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Partici… | Phase 3 | Recruiting | Dec 2028 |
| NCT07518186 | TRIlogy-5 — A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma | Phase 3 | Recruiting | Apr 2029 |
| NCT05552222 | MajesTEC-7 — A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combinatio… | Phase 3 | Recruiting | Apr 2031 |
| NCT05572515 | MajesTEC-9 — A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib,… | Phase 3 | Active, not recruiting | Oct 2025 |
| NCT05083169 | MajesTEC-3 — A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, P… | Phase 3 | Active, not recruiting | Dec 2028 |
| NCT07671287 | AugMMent — GMMG-HD11/DSMM XXI/64007957MMY3010 | Phase 3 | Not yet recruiting | Feb 2031 |
| NCT07649525 | iFIT — Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitn… | Phase 3 | Not yet recruiting | May 2033 |
| NCT05231629 | MASTER-2 — Sequential Therapy in Multiple Myeloma Guided by MRD Assessments | Phase 2 | Recruiting | Dec 2027 |
Related drug pipelines
FAQ
- How many clinical trials are running for teclistamab?
- ClinicalTrials.gov lists more than 16 phase 2–4 teclistamab trials. This page tracks the 16 largest by enrolment: 5 phase 2, 10 phase 3, and 1 phase 4 among them, with 9 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare teclistamab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.